We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 18, 2021

Umbilical Cord Mesenchymal Stem Cells for COVID-19 ARDS

Stem Cells Translational Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

Stem Cells Translational Medicine
Umbilical Cord Mesenchymal Stem Cells for COVID-19 Acute Respiratory Distress Syndrome: A Double-Blind, Phase 1/2a, Randomized Controlled Trial
Stem Cells Transl Med 2021 Jan 05;[EPub Ahead of Print], G Lanzoni, E Linetsky, D Correa, S Messinger Cayetano, RA Alvarez, D Kouroupis, A Alvarez Gil, R Poggioli, P Ruiz, AC Marttos, K Hirani, CA Bell, H Kusack, L Rafkin, D Baidal, A Pastewski, K Gawri, C Leñero, AMA Mantero, SW Metalonis, X Wang, L Roque, B Masters, NS Kenyon, E Ginzburg, X Xu, J Tan, AI Caplan, MK Glassberg, R Alejandro, C Ricordi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading